These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14594598)

  • 1. Erythema dyschromicum perstans and vitiligo.
    Naik NS
    Dermatol Online J; 2003 Oct; 9(4):25. PubMed ID: 14594598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo.
    Gross A; Tapia FJ; Mosca W; Perez RM; Briceño L; Henriquez JJ; Convit J
    Histol Histopathol; 1987 Jul; 2(3):277-83. PubMed ID: 2980730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneously active lesions of vitiligo and erythema dyschromicum perstans.
    Henderson CD; Tschen JA; Schaefer DG
    Arch Dermatol; 1988 Aug; 124(8):1258-60. PubMed ID: 3401033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of erythema dyschromicum perstans and vitiligo: a case report and review of the literature.
    Tamer F
    Acta Dermatovenerol Alp Pannonica Adriat; 2016 Dec; 25(4):77-78. PubMed ID: 28006880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythema dyschromicum perstans and lichen planus.
    Naidorf KF; Cohen SR
    Arch Dermatol; 1982 Sep; 118(9):683-5. PubMed ID: 7114873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapy.
    Baranda L; Torres-Alvarez B; Cortes-Franco R; Moncada B; Portales-Perez DP; Gonzalez-Amaro R
    Arch Dermatol; 1997 Mar; 133(3):325-9. PubMed ID: 9080892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythema dyschromicum perstans. Immunopathologic studies.
    Miyagawa S; Komatsu M; Okuchi T; Shirai T; Sakamoto K
    J Am Acad Dermatol; 1989 May; 20(5 Pt 2):882-6. PubMed ID: 2785541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological changes in common vitiligo].
    Vignale R; Paciel J; Calandria L
    Med Cutan Ibero Lat Am; 1988; 16(4):343-7. PubMed ID: 3068448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathologic study of erythema dyschromicum perstans (ashy dermatosis).
    Vásquez-Ochoa LA; Isaza-Guzmán DM; Orozco-Mora B; Restrepo-Molina R; Trujillo-Perez J; Tapia FJ
    Int J Dermatol; 2006 Aug; 45(8):937-41. PubMed ID: 16911378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythema cinitiensis perstans].
    Sittart JA; Tayah M
    Med Cutan Ibero Lat Am; 1980; 8(1-3):11-4. PubMed ID: 7022047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo associated with regional enteritis.
    Monroe EW
    Arch Dermatol; 1976 Jun; 112(6):833-4. PubMed ID: 942216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo.
    Palermo B; Garbelli S; Mantovani S; Scoccia E; Da Prada GA; Bernabei P; Avanzini MA; Brazzelli V; Borroni G; Giachino C
    Eur J Immunol; 2005 Nov; 35(11):3153-62. PubMed ID: 16224813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythema dyschromicum perstans: a case report and review.
    Osswald SS; Proffer LH; Sartori CR
    Cutis; 2001 Jul; 68(1):25-8. PubMed ID: 11480143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythema dyschromicum perstans (ashy dermatosis)].
    David M; Sandbank M; Feuerman EJ
    Harefuah; 1978 Oct; 95(8):258-9. PubMed ID: 744526
    [No Abstract]   [Full Text] [Related]  

  • 15. Seven cases of vitiligo complicated by atopic dermatitis: suggestive new spectrum of autoimmune vitiligo.
    Tanemura A; Yajima T; Nakano M; Nishioka M; Itoi S; Kotobuki Y; Higashiyama M; Katayama I
    Eur J Dermatol; 2012; 22(2):279-80. PubMed ID: 22381570
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythema dyschromicum perstans.
    Tlougan BE; Gonzalez ME; Mandal RV; Kundu RV; Skopicki D
    Dermatol Online J; 2010 Nov; 16(11):17. PubMed ID: 21163168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo with inflammatory raised borders, associated with atopic dermatitis.
    Sugita K; Izu K; Tokura Y
    Clin Exp Dermatol; 2006 Jan; 31(1):80-2. PubMed ID: 16309491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythema dyschromicum perstans in an HIV antibody-positive man.
    Nelson MR; Lawrence AG; Staughton RC; Gazzard BG
    Br J Dermatol; 1992 Dec; 127(6):658-9. PubMed ID: 1476930
    [No Abstract]   [Full Text] [Related]  

  • 19. Basal cell carcinoma arising in a patient with vitiligo.
    Arnon O; Mamelak AJ; Goldberg LH
    J Drugs Dermatol; 2008 Nov; 7(11):1075-6. PubMed ID: 19110741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythema dyschromicum perstans in a patient with cutaneous melanoma.
    Calista D; Morri M; Riccioni L
    G Ital Dermatol Venereol; 2011 Apr; 146(2):163-4. PubMed ID: 21505402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.